Krister Cromm

679 total citations · 1 hit paper
14 papers, 209 citations indexed

About

Krister Cromm is a scholar working on Nephrology, Surgery and Economics and Econometrics. According to data from OpenAlex, Krister Cromm has authored 14 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 5 papers in Surgery and 5 papers in Economics and Econometrics. Recurrent topics in Krister Cromm's work include Dialysis and Renal Disease Management (13 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Muscle and Compartmental Disorders (4 papers). Krister Cromm is often cited by papers focused on Dialysis and Renal Disease Management (13 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Muscle and Compartmental Disorders (4 papers). Krister Cromm collaborates with scholars based in Germany, Netherlands and United Kingdom. Krister Cromm's co-authors include Andrew Davenport, Cláudia Barth, Matthias Rose, Peter J. Blankestijn, Jörgen Hegbrant, Mark Woodward, Bernard Canaud, Giovanni FM Strippoli, Michiel L. Bots and Robin W.M. Vernooij and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Kidney International.

In The Last Decade

Krister Cromm

11 papers receiving 202 citations

Hit Papers

Effect of Hemodiafiltration or Hemodialysis on Mortality ... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krister Cromm Germany 5 180 90 81 20 18 14 209
Chun-Sang Li China 5 206 1.1× 79 0.9× 96 1.2× 47 2.4× 15 0.8× 14 226
Angelo Testa France 9 198 1.1× 62 0.7× 38 0.5× 29 1.4× 27 1.5× 15 247
Tony Elias Australia 5 266 1.5× 105 1.2× 143 1.8× 25 1.3× 21 1.2× 10 315
G. Suleymanlar Türkiye 2 342 1.9× 188 2.1× 181 2.2× 12 0.6× 21 1.2× 2 370
Sandrine Genestier France 6 144 0.8× 40 0.4× 67 0.8× 38 1.9× 15 0.8× 7 159
M Borrás Spain 3 276 1.5× 117 1.3× 129 1.6× 37 1.9× 13 0.7× 5 288
Philippe Freida France 8 245 1.4× 100 1.1× 124 1.5× 10 0.5× 11 0.6× 9 262
L.-W. Mau United States 4 161 0.9× 18 0.2× 30 0.4× 24 1.2× 18 1.0× 4 184
Inna Kolesnyk Netherlands 7 269 1.5× 69 0.8× 102 1.3× 42 2.1× 46 2.6× 9 303
Giovanna Sau Italy 5 326 1.8× 196 2.2× 167 2.1× 7 0.3× 21 1.2× 7 358

Countries citing papers authored by Krister Cromm

Since Specialization
Citations

This map shows the geographic impact of Krister Cromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krister Cromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krister Cromm more than expected).

Fields of papers citing papers by Krister Cromm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krister Cromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krister Cromm. The network helps show where Krister Cromm may publish in the future.

Co-authorship network of co-authors of Krister Cromm

This figure shows the co-authorship network connecting the top 25 collaborators of Krister Cromm. A scholar is included among the top collaborators of Krister Cromm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krister Cromm. Krister Cromm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fischer, Felix, P. J. Blankestijn, Robin W.M. Vernooij, et al.. (2025). A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis. Kidney International. 107(4). 728–739. 6 indexed citations
2.
Cromm, Krister, Gregor Liegl, Andrew Davenport, et al.. (2024). Psychosocial Determinants for Self-Reported Health Status in Patients on Hemodialysis. Kidney360. 6(1). 76–85.
3.
Liegl, Gregor, Felix Fischer, Bernard Canaud, et al.. (2024). Using a measurement type-independent metric to compare patterns of determinants between patient-reported versus performance-based physical function in hemodialysis patients. Quality of Life Research. 33(11). 2987–3001. 1 indexed citations
4.
Rose, Matthias, Felix Fischer, Gregor Liegl, et al.. (2024). The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration. Kidney International. 106(5). 961–971. 16 indexed citations
5.
Natale, Patrizia, Matthias Rose, Michiel L. Bots, et al.. (2024). Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 19(9). e0309773–e0309773.
6.
Rose, Matthias, Felix Fischer, Carinna Hockham, et al.. (2024). #2502 The CONVINCE randomized trial found positive effects of hemodiafiltration on quality of life in patients with kidney disease on dialysis. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations
7.
Liegl, Gregor, Felix Fischer, Mark Woodward, et al.. (2023). Physical performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis. Journal of Clinical Epidemiology. 159. 128–138. 3 indexed citations
8.
Vernooij, Robin W.M., Carinna Hockham, Cláudia Barth, et al.. (2023). High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial. Kidney International Reports. 8(11). 2276–2283. 3 indexed citations
9.
Cromm, Krister, et al.. (2023). Self-Efficacy and Social Support Determine Self-Reported Health in Hemodialysis Patients. Journal of the American Society of Nephrology. 34(11S). 13–13. 1 indexed citations
10.
Blankestijn, Peter J., Robin W.M. Vernooij, Carinna Hockham, et al.. (2023). Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. New England Journal of Medicine. 389(8). 700–709. 118 indexed citations breakdown →
11.
Vernooij, Robin W.M., Mark Woodward, Jörgen Hegbrant, et al.. (2021). MO812THE COMPARISON OF HIGH-DOSE HAEMODIAFILTRATION WITH HIGH-FLUX HAEMODIALYSIS (CONVINCE) STUDY: BASELINE CHARACTERISTICS AND PROOF OF PRINCIPLE OF THE CONVECTION VOLUME DELIVERED. Nephrology Dialysis Transplantation. 36(Supplement_1).
12.
Blankestijn, Peter J., Cláudia Barth, Krister Cromm, et al.. (2020). Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol. BMJ Open. 10(2). e033228–e033228. 49 indexed citations
14.
Gucht, Véronique De, Krister Cromm, Anja Vogt, et al.. (2018). Treatment-related and health-related quality of life in lipoprotein apheresis patients. Journal of clinical lipidology. 12(5). 1225–1233. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026